| 번호 | 논문제목 | 저자 | 학술지 | 게재일 |
|---|---|---|---|---|
| 1772 | Experimental Verification of Dual Isotope Imaging of Ac-225/Bi-213 For Targeted Alpha Therapy Using Alpha Imaging Detector | 이현수(방사성의약품개발팀,5%), 김병수(방사성의약품개발팀,5%), 강충모(RI인프라응용팀,5%), 임일한(핵의학과3,5%), 이교철(RI응용부,10%), 김종국(방사성의약품개발팀,70%) | Radiation Measurement | 2025-04-02 |
| 1771 | Clinical Utilization and Infrastructure of Radiation Therapy in Korea in 2020 and 2021 | 장원일(방사선종양학과4,25%), 김미숙(방사선종양학과2,5%), 김희진(전략기획팀,10%), 김금배(방사선종양학과,10%), 김정영(기획조정실,5%) | Anticancer Research | 2025-04-01 |
| 1770 | PPM1D Mutation as a Distinct Feature of Myeloid Neoplasms in B-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis | 김혜진(진단검사의학과4,35%), 이진경(한국원자력의학원,25%), 홍영준(진단검사의학과1,10%), 강혜진(혈액종양내과3,10%), 변병현(핵의학과4,10%), 이승숙(병리과1,10%) | cancers | 2025-03-31 |
| 1769 | Developing A System for On-site Dosimetry Audit of High-Dose-Rate Brachytherapy | 권혁준(방사선종양학과,35%), 김금배(방사선치료기술표준팀,25%), 이순성(방사선치료기술표준팀,5%), 조규석(방사선치료기술표준팀,5%), 최상현(방사선치료기술표준팀,15%), 황선붕(방사선종양학과,5%) | Journal of the Korean Physical Society (JKPS) | 2025-03-10 |
| 1768 | Radioactivity evaluation induced by beamline components in the ocular proton treatment | 김상록(방사선안전관리팀,10%) | Nuclear Engineering and Technology | 2025-03-10 |
| 1767 | Basroparib targeting Wnt pathway overcomes acquired resistance to MEK inhibitor in KRAS-mutated colorectal cancer by inhibiting cancer stemness | 김재성(표적치료연구팀,20%), 권영주(표적치료연구팀,30%), 김동영(표적치료연구팀,20%), 김예현(표적치료연구팀,10%) | biochemical pharmacologybiochemci | 2025-02-28 |
| 1766 | Adsorptive performance of rice husk-derived biochar for nodularin cyanotoxin from aqueous solution: Isotherm, kinetic, regeneration, and column studies | 장성재(비상진료규제팀,16%) | Journal of Water Process Engineering | 2025-02-28 |
| 1765 | Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls | 변병현(핵의학과4,5%), 박수연(신경과2,5%), 하정호(신경과1,5%), 이교철(RI응용부,5%), 임상무(국가RI신약센터,10%) | Experimental Neurobiology | 2025-02-28 |
| 1764 | CXCR4 confers stemness and radioresistance in chordoma cells | 정찬웅(방사선바이오소재개발팀,50%), 김정엽(방사선바이오소재개발팀,20%), 박명진(방사선바이오소재개발팀,30%) | Cancer Biology & Therapy | 2025-02-24 |
| 1763 | Cutoff SUVR of [18F]Florapronol PET for Differentiating Alzheimer’s Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume Correction | 박수연(신경과2,30%), 이인기(핵의학과5,5%), 김병일(핵의학과2,5%), 최창운(핵의학과1,5%), 고인옥(RI인프라응용팀,5%), 변병현(핵의학과4,25%), 하정호(신경과1,25%) | Nuclear Medicine and Molecular Imaging | 2025-02-20 |
논문
혁신적 암치료를 선도하는 세계 방사선의학의 중심, 한국원자력의학원
-
- 현재 페이지의 화면이 이해하기 쉽게 구성되어 사용하기에 편리합니까?
-
- 현재 페이지에서 원하는 기능이 충분히 제공되었습니까?
-
- 사용자가 원하는 페이지를 쉽게 찾을 수 있었습니까?
평가하기